文献速递脑血管病

加拿大因血管内卒中治疗而进行的院际转运:OPTIMISE登记研究结果

Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry.
PubMed 文献 · Stroke · 2024-07-22

该研究分析了加拿大OPTIMISE质量改进登记研究中2018年1月1日至2021年12月31日期间在20个中心接受EVT的6803例患者,比较了转运患者与直接就诊患者的基线特征、时间指标和操作结局。转运患者从最后正常时间到动脉穿刺时间更长,90天全因死亡风险更高(29% vs 25%;RR 1.15 [95%CI, 1.05-1.27];校正RR 1.14 [95%CI, 1.03-1.28]),良好功能结局无显著差异。

要点

  • 转运患者从最后正常时间到动脉穿刺时间较直接就诊患者更长(322 vs 181分钟)。
  • 转运患者90天全因死亡风险高于直接就诊患者(29% vs 25%;RR 1.15)。
  • 两组成功再灌注率(85% vs 86%)和良好功能结局(41% vs 43%)无显著差异。

核心结论

  • 接受EVT的转运患者从最后正常时间到EVT启动经历显著延迟。

研究设计与样本

  • 分析OPTIMISE质量改进登记研究数据,该登记旨在支持加拿大EVT实施。
  • 2018年1月1日至2021年12月31日期间,20个参与中心共6803例患者接受EVT,中位年龄73岁,50%为女性,50%接受静脉溶栓治疗。
  • 比较因大血管闭塞转运接受EVT的患者(n=3376)与直接就诊于具备EVT能力中心的患者(n=3373)的未校正基线特征、时间指标和操作结局差异。

主要发现

  • 转运患者M2闭塞率较低(22% vs 27%),基底动脉闭塞率较高(9% vs 5%)。
  • 转运前接受静脉溶栓的患者 door-to-needle 时间较直接就诊于EVT中心者更短(32 vs 36分钟)。
  • 转运患者 door-to-arterial access 时间更短(37 vs 87分钟),但最后正常时间到动脉穿刺时间更长(322 vs 181分钟)。
  • 两组动脉穿刺到再灌注时间、成功再灌注率(85% vs 86%)或围手术期不良事件无差异。
  • 转运患者良好功能结局(改良Rankin量表评分0-2)可能性相似(41% vs 43%;RR 0.95 [95%CI, 0.88-1.01];校正RR 0.98 [95%CI, 0.91-1.05]),90天全因死亡风险更高(29% vs 25%;RR 1.15 [95%CI, 1.05-1.27];校正RR 1.14 [95%CI, 1.03-1.28])。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interhospital transfer for patients with stroke due to large vessel occlusion for endovascular thrombectomy (EVT) has been associated with treatment delays. METHODS: We analyzed data from Optimizing Patient Treatment in Major Ischemic Stroke With EVT, a quality improvement registry to support EVT implementation in Canada. We assessed for unadjusted differences in baseline characteristics, time metrics, and procedural outcomes between patients with large vessel occlusion transferred for EVT and those directly admitted to an EVT-capable center. RESULTS: Between January 1, 2018, and December 31, 2021, a total of 6803 patients received EVT at 20 participating centers (median age, 73 years; 50% women; and 50% treated with intravenous thrombolysis). Patients transferred for EVT (n=3376) had lower rates of M2 occlusion (22% versus 27%) and higher rates of basilar occlusion (9% versus 5%) compared with those patients presenting directly at an EVT-capable center (n=3373). Door-to-needle times were shorter in patients receiving intravenous thrombolysis before transfer compared with those presenting directly to an EVT center (32 versus 36 minutes). Patients transferred for EVT had shorter door-to-arterial access times (37 versus 87 minutes) but longer last seen normal-to-arterial access times (322 versus 181 minutes) compared with those presenting directly to an EVT-capable center. No differences in arterial access-to-reperfusion times, successful reperfusion rates (85% versus 86%), or adverse periprocedural events were found between the 2 groups. Patients transferred to EVT centers had a similar likelihood for good functional outcome (modified Rankin Scale score, 0-2; 41% versus 43%; risk ratio, 0.95 [95% CI, 0.88-1.01]; adjusted risk ratio, 0.98 [95% CI, 0.91-1.05]) and a higher risk for all-cause mortality at 90 days (29% versus 25%; risk ratio, 1.15 [95% CI, 1.05-1.27]; adjusted risk ratio, 1.14 [95% CI, 1.03-1.28]) compared with patients presenting directly to an EVT center. CONCLUSIONS: Patients transferred for EVT experience significant delays from the time they were last seen normal to the initiation of EVT.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Katsanos AH, Poppe A, Swartz RH, et al. Interhospital Transfer for Endovascular Stroke Treatment in Canada: Results From the OPTIMISE Registry. Stroke. 2024. PMID: 39038099. doi:10.1161/STROKEAHA.124.046690

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。